Full Text View
Tabular View
No Study Results Posted
Related Studies
Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer
This study is ongoing, but not recruiting participants.
Study NCT00066391   Information provided by National Cancer Institute (NCI)
First Received: August 6, 2003   Last Updated: February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Penile Cancer
Additional conditions recognized in this trial
Penile Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Penile Diseases
Urogenital Neoplasms
Interventions listed in this trial
cisplatin
irinotecan hydrochloride
neoadjuvant therapy
Additional drug interventions recognized in this trial
Camptothecin
Irinotecan
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
European Organization for Research and Treatment of Cancer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services